Leukocytosis, hypoalbuminemia, and the risk for chronic kidney disease in US adults

被引:61
作者
Erlinger, TP
Tarver-Carr, ME
Powe, NR
Appel, LJ
Coresh, J
Eberhardt, MS
Brancati, FL
机构
[1] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[3] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA
[4] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA
[5] Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA
关键词
white blood cell (WBC) count; kidney; chronic kidney disease (CKD); inflammation; National Health and Nutrition Examination Survey (NHANES);
D O I
10.1016/S0272-6386(03)00650-4
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Atherosclerosis and chronic kidney disease (CKD) share several common antecedents. However, the association between inflammatory markers and incident CKD is unknown. Methods: We determined risk for incident CKD, defined by treatment for kidney failure or death related to kidney disease, in 9,250 US adults aged 30 to 74 years who participated in the Second National Health and Nutrition Examination Survey (NHANES 11), a nationally representative prospective cohort study with 17 years of follow-up. Results After adjusting for age, race, sex, blood pressure, smoking, and body mass index, there was a graded positive association with increasing total white blood cell (WBC) count and risk for CKD (P for trend <0.001; relative hazard (RH) highest versus lowest quartile, 2.34; 95% confidence interval [CI], 1.30 to 4.19). This association remained statistically significant after adjusting further for the presence of diabetes and cardiovascular disease at baseline (RH, 2.01; 95% CI, 1.11 to 3.65). A similarly strong and graded association with incident CKD was observed for hypoalbuminemia after adjusting for age, race, sex, blood pressure, smoking, and body mass index (P for trend = 0.02; RH lowest versus highest quartile, 1.91; 95% CI, 0.89 to 4.07) and additionally adjusting for the presence of diabetes and cardiovascular disease at baseline (P for trend = 0.02; RH lowest versus highest, 2.05; 95% CI, 0.96 to 4.39). Conclusion: In a nationally representative sample of US adults, elevated WBC count and hypoalbuminemia were associated with future risk for CKD. These results support the hypothesis that systemic inflammation is an independent risk factor for CKD.
引用
收藏
页码:256 / 263
页数:8
相关论文
共 24 条
[1]   Prevalence of high blood pressure and elevated serum creatinine level in the United States -: Findings from the Third National Health and Nutrition Examination Survey (1988-1994) [J].
Coresh, J ;
Wei, L ;
McQuillan, G ;
Brancati, FL ;
Levey, AS ;
Jones, C ;
Klag, MJ .
ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (09) :1207-1216
[2]  
CORESH J, 1998, J AM SOC NEPHROL, V9, pA3097
[3]  
CORIA CM, 1999, VITAL HLTH STAT SERI, V1
[4]   Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease - Meta-analyses of prospective studies [J].
Danesh, J ;
Collins, R ;
Appleby, P ;
Peto, R .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (18) :1477-1482
[5]  
Don BR, 2000, J NEPHROL, V13, P249
[6]  
FATTORI E, 1994, BLOOD, V83, P2570
[7]   Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects:: The Insulin Resistance Atherosclerosis Study [J].
Festa, A ;
D'Agostino, R ;
Howard, G ;
Mykkänen, L ;
Tracy, RP ;
Haffner, SM .
KIDNEY INTERNATIONAL, 2000, 58 (04) :1703-1710
[8]   Cardiovascular disease, fibrinogen and the acute phase response Associations with lipids and blood pressure in patients with chronic renal disease [J].
Irish, A .
ATHEROSCLEROSIS, 1998, 137 (01) :133-139
[9]   Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes - The Hoorn study [J].
Jager, A ;
van Hinsbergh, VWM ;
Kostense, PJ ;
Emeis, JJ ;
Nijpels, G ;
Dekker, JM ;
Heine, RJ ;
Bouter, LM ;
Stehouwer, CDA .
DIABETES, 2000, 49 (03) :485-491
[10]   Prevention and treatment of experimental crescentic glomerulonephritis by blocking tumour necrosis factor-α [J].
Karkar, AM ;
Charles, JS ;
Pusey, CD .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (03) :518-524